New Delhi: Serum Institute of India (SII) on Thursday said it is pausing clinical trials of AstraZeneca Oxford COVID-19 vaccine candidate in the country. Earlier this week, AstraZeneca said it had paused the trials because of ‘an unexplained illness’ in a participant in the study. However, SII on Wednesday said it was continuing with the […]
Read MoreNew Delhi: India is considering Russia’s request for conducting phase-3 clinical trial and manufacturing of its COVID-19 vaccine Sputnik V by Indian firms, officials said Tuesday, noting there has been “significant movement” on both these fronts and specific outcomes are expected soon. Dr V K Paul, Member (Health) Niti Aayog, who also chairs the national expert […]
Read MorePune: The Phase II clinical trial of the Oxford COVID-19 vaccine, being manufactured by the city-based Serum Institute of India (SII), began at a medical college and hospital here on Wednesday. Two male volunteers were administered the vaccine at Bharti Vidyapeeth’s Medical College and Hospital, a senior office-bearer of the hospital said. The trial began […]
Read MoreNew Delhi: Serum Institute of India, (SII) on Friday said it?has entered into a new partnership with international vaccine alliance Gavi and Bill & Melinda Gates Foundation to accelerate manufacturing and delivery of up to 100 million doses of COVID-19 vaccines for India as well as other low and middle-income countries (LMICs) “The collaboration will […]
Read MorePune: Vaccine maker Serum Institute of India (SII) is hoping to develop a COVID-19 vaccine by the year-end as it is focusing on a “good and safe” product and is not in a “rush”, the company’s CEO Adar Poonawalla said on Tuesday. He was speaking during the launch of ‘Compact XL, a compact diagnostics machine by MyLab Discovery Solutions, […]
Read More